FDA
approval
· 2020-05-28
FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
Summary
FDA approved a supplemental application for buspirone hydrochloride from Oxford Pharmaceuticals, LLC under the Abbreviated New Drug Application (ANDA) process.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)